COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 5th, 2021 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 5th, 2021 Company Industry JurisdictionTHIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of March 31, 2015 (the “ Effective Date ”), by and between NEUROCRINE BIOSCIENCES , I NC . , a Delaware corporation (“ Neurocrine ”), having an address of 12780 El Camino Real, San Diego, CA 92130, U.S., and MITSUBISHI TANABE PHARMA CORPORATION , a corporation organized under the laws of Japan (“ MTPC ”), having an address of 6-18, Kitahama 2-chome, Chuo-ku, Osaka 541-8505, Japan. Neurocrine and MTPC may be referred to herein individually as a “ Party ” or collectively as the “ Parties ”.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • April 30th, 2015 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 30th, 2015 Company Industry JurisdictionNotwithstanding the foregoing, in case the daily drug price of the Product determined by Regulatory Authority is lower than […***…], then the Milestone Payment of $[…***…] on […***…] is to be a credit against the royalties payable to Neurocrine pursuant to the Section 8.3.